Xiaoxia Wei

11PUBLICATIONS
10CO-AUTHORS
Haematological tumoursMolecular targetsPharmacogenomicsPredictive and prognostic markersEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 28, 2026
Association of haematological cancer drugs recommendation levels in Chinese Society of Clinical Oncology guideline with different approval approaches: a cross-sectional study.

|Aug 14, 2025
Two Birds With One Stone: The Protective Role of the Antidiabetic Drug Sodium-Glucose Cotransporter-2 Inhibitor in Neurodegenerative Diseases.

LiRong Zhang, Liangchun Cai, Huiting Lin

|Oct 08, 2024
Cost-effectiveness of finerenone added to standard of care for patients with type 2 diabetes-related chronic kidney disease in the United States.

Cailin Zheng, Jinneng Wu, Na Li

|Oct 01, 2024
Cost-effectiveness analysis of selpercatinib versus chemotherapy and pembrolizumab in the first-line treatment of rearranged during transfection fusion-positive non-small cell lung cancer in the United States.

Hongbin Yi, Yingdan Cao, Fenghao Shi

|Sep 29, 2024
Relationship between serum vitamin D levels and thyroid- and parathyroid-related diseases: a Mendelian randomisation study.

Lirong Zhang, Congting Hu, Xinmiao Lin

|Aug 17, 2024
SGLT-2 inhibitors are beneficial in reducing the risk of thyroid cancer: findings from a Mendelian randomization study.

LiRong Zhang, Jiaqin Cai, Huiting Lin

Pageof 2

Frequent Collaborators

3 joint publications

Hongbin Yi

2 joint publications

Yingdan Cao

2 joint publications

Fenghao Shi

2 joint publications

Sheng Han